|
π
|
Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the Ξ±5 Subunit of the GABAAReceptor
15 auth.
N. Collinson,
F. Kuenzi,
W. Jarolimek,
K. Maubach,
Rosa Cothliff,
C. Sur,
Alison J. Smith,
F. Otu,
O. Howell,
J. Atack,
...
R. Mckernan,
G. Seabrook,
G. Dawson,
P. Whiting,
T. Rosahl
|
9 |
2002 |
9
π
|
|
π
|
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
7 auth.
J. Bowes,
A. J. Brown,
J. Hamon,
W. Jarolimek,
A. Sridhar,
Gareth J Waldron,
...
S. Whitebread
|
9 |
2012 |
9
π
|
|
π’
|
A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system
U. Misgeld,
M. Bijak,
W. Jarolimek
|
8 |
1995 |
8
π’
|
|
π¦
|
A Furosemide-Sensitive K+βClβCotransporter Counteracts Intracellular Clβ Accumulation and Depletion in Cultured Rat Midbrain Neurons
W. Jarolimek,
A. Lewen,
U. Misgeld
|
7 |
1999 |
7
π¦
|
|
π¬
|
Mannitol Enhances Antibiotic Sensitivity of Persister Bacteria in Pseudomonas aeruginosa Biofilms
N. Barraud,
A. Buson,
W. Jarolimek,
S. Rice
|
7 |
2013 |
7
π¬
|
|
π
|
Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4-Hydroxy-5-iodo-3-methoxyphenylacetate ester) Iodo-Resiniferatoxin
14 auth.
G. Seabrook,
K. Sutton,
W. Jarolimek,
G. Hollingworth,
S. Teague,
J. Webb,
N. Clark,
S. Boyce,
J. Kerby,
Z. Ali,
...
M. Chou,
R. Middleton,
G. Kaczorowski,
A. B. Jones
|
7 |
2002 |
7
π
|
|
π
|
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis
34 auth.
Mark G. Jones,
O. Andriotis,
J. Roberts,
Kerry Lunn,
V. Tear,
Lucy Cao,
K. Ask,
D. Smart,
A. Bonfanti,
P. Johnson,
A. Alzetani,
F. Conforti,
R. Doherty,
C. Lai,
Benjamin Johnson,
...
K. Bourdakos,
S. Fletcher,
B. Marshall,
S. Jogai,
C. Brereton,
S. Chee,
C. Ottensmeier,
P. Sime,
J. Gauldie,
M. Kolb,
S. Mahajan,
A. Fabre,
A. Bhaskar,
W. Jarolimek,
L. Richeldi,
K. O'Reilly,
P. Monk,
P. Thurner,
D. Davies
|
6 |
2018 |
6
π
|
|
π
|
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
12 auth.
Joan Chang,
M. Lucas,
L. E. Leonte,
Marc GarcΓa-Montolio,
L. Singh,
A. Findlay,
...
Mandar Deodhar,
J. Foot,
W. Jarolimek,
P. Timpson,
J. Erler,
T. Cox
|
6 |
2017 |
6
π
|
|
π’
|
The lysyl oxidase like 2/3 enzymatic inhibitor, PXSβ5153A, reduces crosslinks and ameliorates fibrosis
16 auth.
H. Schilter,
A. Findlay,
L. Perryman,
T. Yow,
Joshua Moses,
Amna Zahoor,
C. Turner,
Mandar Deodhar,
J. Foot,
Wenbin Zhou,
...
A. GrΓ©co,
A. Joshi,
B. Rayner,
Sarah Townsend,
A. Buson,
W. Jarolimek
|
6 |
2018 |
6
π’
|
|
π¦
|
Activity dependent alkaline and acid transients in guinea pig hippocampal slices
W. Jarolimek,
U. Misgeld,
H. Lux
|
6 |
1989 |
6
π¦
|
|
π¦
|
GABAB Receptor-Mediated Inhibition of Tetrodotoxin-Resistant GABA Release in Rodent Hippocampal CA1 Pyramidal Cells
W. Jarolimek,
U. Misgeld
|
5 |
1997 |
5
π¦
|
